HUL Q3 net profit more than doubles to ₹6,607 crore on demerger gain | Company Results

Hindustan Unilever (HUL) saw more than two-fold increase in its consolidated net profit in the October-December quarter (Q3) of the financial year, aided by the one-time positive impact from the freeze split, which was accounted for in accordance with the approved plan and applicable accounting standards.

Net profit reported stood at ₹6,607 crore. Excluding exceptional items, profit after tax (PAT) at ₹2,562 crore rose 1 per cent year-on-year.

Underlying volume growth stood at 4 percent in the quarter. Net sales grew 5.6 per cent to ₹16,441 billion in the quarter ended December.

Priya Nair, Chief Executive Officer and Managing Director of HUL, said in the results statement: “Demand trends during the quarter reflected early signs of recovery, supported by supportive policy measures. Against this backdrop, we delivered a competitive performance with revenue growth of 6 percent and underlying volume growth of 4 percent.”

“We have continued to build desirability with our brands at scale, accelerate market development in high-growth demand areas, and strengthen our capabilities to scale Channels of the Future with a dedicated organization for fast-paced commerce. As market leaders in fast-moving consumer goods (FMCG), our commitment to building modern brands, building categories and investing disproportionately to build future moats positions us well to deliver volume-led sustainable growth and create long-term shareholder value,” Nair added.

Portfolio moves in health and wellbeing

HUL, the maker of Dove soaps, also announced that it has transferred its 19.8 per cent stake in Nutritionalab Private Limited (Wellbeing Nutrition) to USV Private Limited for Rs 307 crore. It is also acquiring the entirety of Zywie Ventures Private Limited (OZiva) for ₹824 crore.

“Since entering the health and well-being (H&W) category in 2023, HUL has focused on building a strong presence in this emerging but fast-growing consumer space. OZiva has delivered a strong performance following HUL’s 51 per cent majority investment – growing at a compound annual growth rate of 130 per cent over the last two years to around Rs 480 million crore in 2025, by developing a winning portfolio and unlocking significant synergies through HUL’s ecosystem,” he said. company.

The Board of Directors approved the acquisition of the remaining 49 per cent stake in OZiva for ₹824 million as per the previously agreed valuation framework, making OZiva a wholly owned subsidiary.

The company expects both transactions to be completed by March, subject to customary closing conditions.

“Health and Wellbeing is a key growth vector for us and is driven by growing consumer interest in daily wellness. By taking full ownership of OZiva, we are doubling down on this space to unlock the next phase of growth. Our decisions today reflect our intention to make fewer, bigger bets where we can leverage HUL’s strengths in science, distribution and market development to scale purpose-driven brands,” Nair said.